Login / Signup

The combination of emicizumab and recombinant factor VIII in plasma: Which assays can we use for accurate measurement?

Annette Elizabeth BowyerRhona M MacleanSteve Kitchen
Published in: International journal of laboratory hematology (2023)
Modified OSA and human FX CSA could not distinguish between rFVIII or emicizumab. The presence of both emicizumab and rFVIII increased thrombin generation to normal levels compared to each drug alone. Bovine FX CSA can be used to accurately determine FVIII activity of rFVIII in plasma which also contains emicizumab.
Keyphrases
  • endothelial cells
  • obstructive sleep apnea
  • high throughput
  • induced pluripotent stem cells
  • high resolution
  • emergency department
  • pluripotent stem cells
  • adverse drug
  • mass spectrometry